NCT07388992Recruiting
Investigating Specific Gait Patterns in Individuals Living With Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 23 Mar 2026
Brief summary (registry, in English)
The study aims to investigate specific ambulation patterns characteristic of the quality of gait in people with MS (pwMS)
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 28 Jan 2026
- Start date
- 16 Mar 2026
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- SYSNAV
- Diseases
- Multiple sclerosis
- NCT number
- NCT07388992
What you commit to
- Study type: Observational
- Planned participants: 30
- From 16 Mar 2026 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants with a relapse within the past 3 months before the inclusion
- Past or present pathology other than MS or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator
- Past or present pathology or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator
Other illness
- Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator
- Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator
Other
- For pwMS:
- Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent.
- For healthy volunteers (HV):
- Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent.
Who the study is looking for
- For people living with multiple sclerosis (pwMS):
- Age at inclusion between =18 and =65 years old
- Signed informed consent and ability to comply with study and follow-up.
- Confirmed MS diagnosis according to McDonald criteria (2017)
- Expanded Disability Status Scale EDSS = 6
- Stable treatment for 2 months before inclusion (for both disease modifying and symptomatic therapies)
- Ability and willingness to participate in and comply with all study procedures defined in the protocol
- Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category
- For Healthy volunteers :
- Age at inclusion between =18 and =65 years old
- Signed informed consent and ability to comply with study and follow-up.
- Ability and willingness to participate in and comply with all study procedures defined in the protocol
- Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Lille Coordinator of this site? Confirm its status | Lille | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.